Oncology (Williston Park). 2024 Jun 10;38(6):239-241. doi: 10.46883/2024.25921023.
ABSTRACT
The June Hot Topics focuses on the challenges venetoclax regimens have faced in multiple myeloma trials.
PMID:38899981 | DOI:10.46883/2024.25921023
Recent Content
- Sex-specific dysregulation of exosomal non-coding RNAs drives multiple myeloma progression
- Comparative efficacy and safety of BCMA-targeted CAR T cells and BiTEs in relapsed/refractory multiple myeloma: a meta-analysis of interventional and real-world studies
- (no title)
- FDA OK’s belantamab mafodotin-blmf for multiple myeloma
- Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value
- (no title)
- (no title)
- (no title)
- Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study
- (no title)